1. Home
  2. VMI vs RGEN Comparison

VMI vs RGEN Comparison

Compare VMI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valmont Industries Inc.

VMI

Valmont Industries Inc.

HOLD

Current Price

$445.59

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$167.44

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMI
RGEN
Founded
1946
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VMI
RGEN
Price
$445.59
$167.44
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$462.00
$177.18
AVG Volume (30 Days)
130.0K
570.0K
Earning Date
02-17-2026
02-19-2026
Dividend Yield
0.61%
N/A
EPS Growth
N/A
N/A
EPS
11.66
0.03
Revenue
$4,103,136,000.00
$707,890,000.00
Revenue This Year
$1.84
$17.86
Revenue Next Year
$4.07
$12.44
P/E Ratio
$38.10
$6,679.64
Revenue Growth
1.23
11.74
52 Week Low
$250.07
$102.97
52 Week High
$447.25
$182.52

Technical Indicators

Market Signals
Indicator
VMI
RGEN
Relative Strength Index (RSI) 65.34 54.26
Support Level $431.24 $157.29
Resistance Level $447.07 $172.51
Average True Range (ATR) 11.46 6.72
MACD 2.15 -0.25
Stochastic Oscillator 95.44 54.36

Price Performance

Historical Comparison
VMI
RGEN

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: